Advertisement

Venous Thromboembolism in Brain Tumor Patients

Chapter
First Online:
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 906)

Abstract

Venous thromboembolism (VTE) is a common medical condition, particularly after surgical interventions. Many studies have shown that development of VTE, including both deep vein thrombosis (DVT) and pulmonary embolism (PE), is more common in surgical patients with cancer than in patients without cancer. This chapter focuses on VTE in brain tumor patients, including their pathogenesis, presentation, diagnosis, and treatment. Topics discussed included a brief overview of VTE followed by an in-depth discussion of the VTE risks brain tumor patients face in the post-operative period. We conclude with a summary of various recommendations on VTE prophylaxis and a discussion of the controversial nature of VTE chemoprophylaxis for patients undergoing transcranial operations for brain tumors.

Keywords

Venous thromboembolism Deep venous thrombosis Neurosurgery Brain tumors Brain surgery Prophylaxis Thromboprophylaxis Anti-coagulation Pulmonary embolism 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    (2008) The surgeon general’s call to action to prevent deep vein thrombosis and pulmonary embolism. Publications and Reports of the Surgeon General, Rockville, MDGoogle Scholar
  2. 2.
    Hill J, Treasure T, National Clinical Guideline Centre for Acute, Chronic Conditions (2010) Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance. BMJ 340:c95Google Scholar
  3. 3.
    Now CSH. Venous Thromboembolism (VTE)-saferhealthcarenow.ca: Canadian Safer Healthcare Now 2012 [cited 2015 16/4/2015]. Available from: http://www.saferhealthcarenow.ca/EN/Interventions/vte/Pages/default.aspx
  4. 4.
    Fowkes FJ, Price JF, Fowkes FG (2003) Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 25(1):1–5CrossRefPubMedGoogle Scholar
  5. 5.
    Saha P, Humphries J, Modarai B, Mattock K, Waltham M, Evans CE et al (2011) Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions. Arterioscler Thromb Vasc Biol 31(3):506–512CrossRefPubMedGoogle Scholar
  6. 6.
    Centers for Disease Control and Prevention (2012) Venous thromboembolism in adult hospitalizations – United States, 2007–2009. MMWR Morb Mortal Wkly Rep 61(22):401–404Google Scholar
  7. 7.
    Tapson VF (2008) Acute pulmonary embolism. N Engl J Med 358(10):1037–1052CrossRefPubMedGoogle Scholar
  8. 8.
    Ruppert A, Steinle T, Lees M (2011) Economic burden of venous thromboembolism: a systematic review. J Med Econ 14(1):65–74CrossRefPubMedGoogle Scholar
  9. 9.
    Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC (2013) Epidemiology of cancer-associated venous thrombosis. Blood 122(10):1712–1723CrossRefPubMedGoogle Scholar
  10. 10.
    Brandes AA, Scelzi E, Salmistraro G, Ermani M, Carollo C, Berti F et al (1997) Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study. Eur J Cancer 33(10):1592–1596CrossRefPubMedGoogle Scholar
  11. 11.
    Rodas RA, Fenstermaker RA, McKeever PE, Blaivas M, Dickinson LD, Papadopoulos SM et al (1998) Correlation of intraluminal thrombosis in brain tumor vessels with postoperative thrombotic complications: a preliminary report. J Neurosurg 89(2):200–205CrossRefPubMedGoogle Scholar
  12. 12.
    Marras LC, Geerts WH, Perry JR (2000) The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer 89(3):640–646CrossRefPubMedGoogle Scholar
  13. 13.
    Walsh DC, Kakkar AK (2001) Thromboembolism in brain tumors. Curr Opin Pulm Med 7(5):326–331CrossRefPubMedGoogle Scholar
  14. 14.
    Smith SF, Simpson JM, Sekhon LH (2004) Prophylaxis for deep venous thrombosis in neurosurgical oncology: review of 2779 admissions over a 9-year period. Neurosurg Focus 17(4), E4CrossRefPubMedGoogle Scholar
  15. 15.
    Streiff MB, Segal J, Grossman SA, Kickler TS, Weir EG (2004) ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas. Cancer 100(8):1717–1723CrossRefPubMedGoogle Scholar
  16. 16.
    Chiocca EA, Schwartzbaum JA (2007) Gliomas and venous thromboembolism: how common? J Neurosurg 106(4):599–600; discussionGoogle Scholar
  17. 17.
    Semrad TJ, O’Donnell R, Wun T, Chew H, Harvey D, Zhou H et al (2007) Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg 106(4):601–608CrossRefPubMedGoogle Scholar
  18. 18.
    Ghanim AJ, Daskalakis C, Eschelman DJ, Kraft WK (2007) A five-year, retrospective, comparison review of survival in neurosurgical patients diagnosed with venous thromboembolism and treated with either inferior vena cava filters or anticoagulants. J Thromb Thrombolysis 24(3):247–254CrossRefPubMedGoogle Scholar
  19. 19.
    Jenkins EO, Schiff D, Mackman N, Key NS (2010) Venous thromboembolism in malignant gliomas. J Thromb Haemost 8(2):221–227CrossRefPubMedGoogle Scholar
  20. 20.
    Lima J (2011) Venous thromboembolism and gliomas: the need for increased vigilance. Clin J Oncol Nurs 15(6):687–690CrossRefPubMedGoogle Scholar
  21. 21.
    Smith TR, Lall RR, Graham RB, McClendon J Jr, Lall RR, Nanney AD et al (2014) Venous thromboembolism in high grade glioma among surgical patients: results from a single center over a 10 year period. J Neurooncol 120(2):347–352CrossRefPubMedGoogle Scholar
  22. 22.
    Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE (2006) Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 119(1):60–68CrossRefPubMedGoogle Scholar
  23. 23.
    Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R et al (1999) Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine 78(5):285–291CrossRefPubMedGoogle Scholar
  24. 24.
    Smith TR, Nanney AD, 3rd, Lall RR, Graham RB, McClendon J, Jr., Lall RR et al (2014) Development of venous thromboembolism (VTE) in patients undergoing surgery for brain tumors: results from a single center over a 10 year period. J Clin Neurosci, 2015 March; 22(3):519–25Google Scholar
  25. 25.
    Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343(25):1846–1850CrossRefPubMedGoogle Scholar
  26. 26.
    Edwards RLRF (1984) Hemostatic alterations in cancer patients. In: Honn KVLS (ed) Hemostatic mechanism and metastases. Nishoff, Boston, pp 342–354CrossRefGoogle Scholar
  27. 27.
    Lieberman JSBJ, Urdaneta E, Wright IS (1961) Thrombophlebitis and cancer. J Am Med Assoc 177(8):542–545CrossRefGoogle Scholar
  28. 28.
    Rickles FR, Edwards RL (1983) Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood 62(1):14–31PubMedGoogle Scholar
  29. 29.
    Soong BC, Miller SP (1970) Coagulation disorders in cancer. 3. Fibrinolysis and inhibitors. Cancer 25(4):867–874CrossRefPubMedGoogle Scholar
  30. 30.
    Dipasco PJ, Misra S, Koniaris LG, Moffat FL Jr (2011) Thrombophilic state in cancer, part I: biology, incidence, and risk factors. J Surg Oncol 104(3):316–322CrossRefPubMedGoogle Scholar
  31. 31.
    Wakefield TW, Myers DD, Henke PK (2008) Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol 28(3):387–391CrossRefPubMedGoogle Scholar
  32. 32.
    Falanga A, Marchetti M, Vignoli A (2013) Coagulation and cancer: biological and clinical aspects. J Thromb Haemost 11(2):223–233CrossRefPubMedGoogle Scholar
  33. 33.
    Bostrom S, Holmgren E, Jonsson O, Lindberg S, Lindstrom B, Winso I et al (1986) Post-operative thromboembolism in neurosurgery. A study on the prophylactic effect of calf muscle stimulation plus dextran compared to low-dose heparin. Acta Neurochir (Wien) 80(3–4):83–89CrossRefGoogle Scholar
  34. 34.
    Cerrato D, Ariano C, Fiacchino F (1978) Deep vein thrombosis and low-dose heparin prophylaxis in neurosurgical patients. J Neurosurg 49(3):378–381CrossRefPubMedGoogle Scholar
  35. 35.
    Valladares JB, Hankinson J (1980) Incidence of lower extremity deep vein thrombosis in neurosurgical patients. Neurosurgery 6(2):138–141CrossRefPubMedGoogle Scholar
  36. 36.
    Tapaninaho A (1985) Deep vein thrombosis after aneurysm surgery. Acta Neurochir (Wien) 74(1–2):18–20CrossRefGoogle Scholar
  37. 37.
    Voth D, Schwarz M, Hahn K, Dei-Anang K, al Butmeh S, Wolf H (1992) Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen. Neurosurg Rev 15(4):289–294PubMedGoogle Scholar
  38. 38.
    Hamilton MG, Hull RD, Pineo GF (1994) Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurgery 34(2):280–296; discussion 96CrossRefPubMedGoogle Scholar
  39. 39.
    Agnelli G (2004) Prevention of venous thromboembolism in surgical patients. Circulation 110(24 Suppl 1):IV4–IV12PubMedGoogle Scholar
  40. 40.
    Gerlach R, Raabe A, Beck J, Woszczyk A, Seifert V (2004) Postoperative nadroparin administration for prophylaxis of thromboembolic events is not associated with an increased risk of hemorrhage after spinal surgery. Eur Spine J 13(1):9–13CrossRefPubMedGoogle Scholar
  41. 41.
    Raj D, Marshall RW (2008) Prophylaxis against thromboembolism in spinal surgery. Arch Orthop Trauma Surg 128(12):1365–1371CrossRefPubMedGoogle Scholar
  42. 42.
    Day JS, Ramsey ML, Lau E, Williams GR (2015) Risk of venous thromboembolism after shoulder arthroplasty in the Medicare population. J Am Shoulder Elb Surg 24(1):98–105CrossRefGoogle Scholar
  43. 43.
    Chan AT, Atiemo A, Diran LK, Licholai GP, McLaren Black P, Creager MA et al (1999) Venous thromboembolism occurs frequently in patients undergoing brain tumor surgery despite prophylaxis. J Thromb Thrombolysis 8(2):139–142CrossRefPubMedGoogle Scholar
  44. 44.
    Rolston JD, Han SJ, Bloch O, Parsa AT (2014) What clinical factors predict the incidence of deep venous thrombosis and pulmonary embolism in neurosurgical patients? J Neurosurg 121(4):908–918CrossRefPubMedGoogle Scholar
  45. 45.
    Brooks EG, Trotman W, Wadsworth MP, Taatjes DJ, Evans MF, Ittleman FP et al (2009) Valves of the deep venous system: an overlooked risk factor. Blood 114(6):1276–1279CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Joffe HV, Kucher N, Tapson VF, Goldhaber SZ (2004) Deep vein thrombosis FSC. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 110(12):1605–1611CrossRefPubMedGoogle Scholar
  47. 47.
    Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr (1994) The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 154(8):861–866CrossRefPubMedGoogle Scholar
  48. 48.
    Stein PD, Hull RD, Kayali F, Ghali WA, Alshab AK, Olson RE (2004) Venous thromboembolism according to age: the impact of an aging population. Arch Intern Med 164(20):2260–2265CrossRefPubMedGoogle Scholar
  49. 49.
    Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr et al (2001) Prevention of venous thromboembolism. Chest 119(1 Suppl)):132s–175sCrossRefPubMedGoogle Scholar
  50. 50.
    Merkow RP, Bilimoria KY, McCarter MD, Cohen ME, Barnett CC, Raval MV et al (2011) Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis. Ann Surg 254(1):131–137CrossRefPubMedGoogle Scholar
  51. 51.
    De Martino RR, Goodney PP, Spangler EL, Wallaert JB, Corriere MA, Rzucidlo EM et al (2012) Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg 55(4):1035–1040, e4CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Bastida E, Ordinas A, Escolar G, Jamieson GA (1984) Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. Blood 64(1):177–184PubMedGoogle Scholar
  53. 53.
    Khorana AA, Francis CW, Menzies KE, Wang JG, Hyrien O, Hathcock J et al (2008) Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost 6(11):1983–1985CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Kleindienst A, Harvey HB, Mater E, Bronst J, Flack J, Herenz K et al (2003) Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery. Acta Neurochir (Wien) 145(12):1085–1090, discussion 90–1CrossRefGoogle Scholar
  55. 55.
    Callander NS, Varki N, Rao LV (1992) Immunohistochemical identification of tissue factor in solid tumors. Cancer 70(5):1194–1201CrossRefPubMedGoogle Scholar
  56. 56.
    Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC et al (2009) Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 15(22):6830–6840CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Sartori MT, Della Puppa A, Ballin A, Saggiorato G, Bernardi D, Padoan A et al (2011) Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles. J Neuro-Oncol 104(1):225–231CrossRefGoogle Scholar
  58. 58.
    Sevitt S (1973) The vascularisation of deep-vein thrombi and their fibrous residue: a post mortem angio-graphic study. J Pathol 111(1):1–11CrossRefPubMedGoogle Scholar
  59. 59.
    Hara Y, Steiner M, Baldini MG (1980) Characterization of the platelet-aggregating activity of tumor cells. Cancer Res 40(4):1217–1222PubMedGoogle Scholar
  60. 60.
    Bucek RA, Reiter M, Quehenberger P, Minar E (2002) C-reactive protein in the diagnosis of deep vein thrombosis. Br J Haematol 119(2):385–389CrossRefPubMedGoogle Scholar
  61. 61.
    Bauer KA, ten Cate H, Barzegar S, Spriggs DR, Sherman ML, Rosenberg RD (1989) Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 74(1):165–172PubMedGoogle Scholar
  62. 62.
    Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD (2000) Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A 97(25):13835–13840CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Ay C, Simanek R, Vormittag R, Dunkler D, Alguel G, Koder S et al (2008) High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna cancer and thrombosis study (CATS). Blood 112(7):2703–2708CrossRefPubMedGoogle Scholar
  64. 64.
    Stein PD, Gottschalk A, Saltzman HA, Terrin ML (1991) Diagnosis of acute pulmonary embolism in the elderly. J Am Coll Cardiol 18(6):1452–1457CrossRefPubMedGoogle Scholar
  65. 65.
    Kokturk N, Oguzulgen IK, Demir N, Demirel K, Ekim N (2005) Differences in clinical presentation of pulmonary embolism in older vs younger patients. Circ J 69(8):981–986CrossRefPubMedGoogle Scholar
  66. 66.
    Le Gal G, Bounameaux H (2004) Diagnosing pulmonary embolism: running after the decreasing prevalence of cases among suspected patients. J Thromb Haemost 2(8):1244–1246CrossRefPubMedGoogle Scholar
  67. 67.
    Attia J, Ray JG, Cook DJ, Douketis J, Ginsberg JS, Geerts WH (2001) Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med 161(10):1268–1279CrossRefPubMedGoogle Scholar
  68. 68.
    Geerts WH, Jay RM, Code KI, Chen E, Szalai JP, Saibil EA et al (1996) A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 335(10):701–707CrossRefPubMedGoogle Scholar
  69. 69.
    Bajaj N, Bozarth AL, Guillot J, Kojokittah J, Appalaneni SR, Cestero C et al (2014) Clinical features in patients with pulmonary embolism at a community hospital: analysis of 4 years of data. J Thromb Thrombolysis 37(3):287–292CrossRefPubMedGoogle Scholar
  70. 70.
    Wells PS, Anderson DR, Bormanis J, Guy F, Mitchell M, Gray L et al (1997) Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 350(9094):1795–1798CrossRefPubMedGoogle Scholar
  71. 71.
    Tamariz LJ, Eng J, Segal JB, Krishnan JA, Bolger DT, Streiff MB et al (2004) Usefulness of clinical prediction rules for the diagnosis of venous thromboembolism: a systematic review. Am J Med 117(9):676–684CrossRefPubMedGoogle Scholar
  72. 72.
    Michiels JJ, Gadisseur A, van der Planken M, Schroyens W, De Maeseneer M, Hermsen JT et al (2005) Screening for deep vein thrombosis and pulmonary embolism in outpatients with suspected DVT or PE by the sequential use of clinical score: a sensitive quantitative D-dimer test and noninvasive diagnostic tools. Semin Vasc Med 5(4):351–364CrossRefPubMedGoogle Scholar
  73. 73.
    Malatino L, Cardella AM, Puccia G, Cilia C, Terranova V, Cataudella E et al (2015) Testing clinical scores to diagnose incident deep vein thrombosis in patients hospitalized in a department of medicine: can biomarkers improve accuracy? Angiology, 19 May 2015; [epub ahead of print]Google Scholar
  74. 74.
    Swann KW, Black PM (1984) Deep vein thrombosis and pulmonary emboli in neurosurgical patients: a review. J Neurosurg 61(6):1055–1062CrossRefPubMedGoogle Scholar
  75. 75.
    Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA et al (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e227S–e277SCrossRefPubMedPubMedCentralGoogle Scholar
  76. 76.
    Caprini JA (2010) Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. Am J Surg 199(1 Suppl):S3–S10CrossRefPubMedGoogle Scholar
  77. 77.
    Dickinson LD, Miller LD, Patel CP, Gupta SK (1998) Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery 43(5):1074–1081CrossRefPubMedGoogle Scholar
  78. 78.
    Norwood SH, McAuley CE, Berne JD, Vallina VL, Kerns DB, Grahm TW et al (2001) A potentially expanded role for enoxaparin in preventing venous thromboembolism in high risk blunt trauma patients. J Am Coll Surg 192(2):161–167CrossRefPubMedGoogle Scholar
  79. 79.
    Simonneau G, Sors H, Charbonnier B, Page Y, Laaban JP, Azarian R et al (1997) A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou heparine standard: evaluations dans l’Embolie Pulmonaire. N Engl J Med 337(10):663–669CrossRefPubMedGoogle Scholar
  80. 80.
    Kim J, Gearhart MM, Zurick A, Zuccarello M, James L, Luchette FA (2002) Preliminary report on the safety of heparin for deep venous thrombosis prophylaxis after severe head injury. J Trauma 53(1):38–42, discussion 3CrossRefPubMedGoogle Scholar
  81. 81.
    (1997) Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. The Columbus Investigators. N Engl J Med 337(10):657–662Google Scholar
  82. 82.
    Danish SF, Burnett MG, Ong JG, Sonnad SS, Maloney-Wilensky E, Stein SC (2005) Prophylaxis for deep venous thrombosis in craniotomy patients: a decision analysis. Neurosurgery 56(6):1286–1292; discussion 92–4CrossRefPubMedGoogle Scholar
  83. 83.
    Collen JF, Jackson JL, Shorr AF, Moores LK (2008) Prevention of venous thromboembolism in neurosurgery: a metaanalysis. Chest 134(2):237–249CrossRefPubMedGoogle Scholar
  84. 84.
    Kurtoglu M, Yanar H, Bilsel Y, Guloglu R, Kizilirmak S, Buyukkurt D et al (2004) Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin. World J Surg 28(8):807–811CrossRefPubMedGoogle Scholar
  85. 85.
    Clagett GP, Anderson FA Jr, Geerts W, Heit JA, Knudson M, Lieberman JR et al (1998) Prevention of venous thromboembolism. Chest 114(5 Suppl):531S–560SCrossRefPubMedGoogle Scholar
  86. 86.
    Velmahos GC, Nigro J, Tatevossian R, Murray JA, Cornwell EE 3rd, Belzberg H et al (1998) Inability of an aggressive policy of thromboprophylaxis to prevent deep venous thrombosis (DVT) in critically injured patients: are current methods of DVT prophylaxis insufficient? J Am Coll Surg 187(5):529–533CrossRefPubMedGoogle Scholar
  87. 87.
    Marti C, John G, Konstantinides S, Combescure C, Sanchez O, Lankeit M et al (2015) Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 36(10):605–614CrossRefPubMedGoogle Scholar
  88. 88.
    McMahon CM, Cuker A (2014) Hospital-acquired thrombocytopenia. Hosp Pract (1995) 42(4):142–152Google Scholar
  89. 89.
    Van Ryn-McKenna J, Cai L, Ofosu FA, Hirsh J, Buchanan MR (1990) Neutralization of enoxaparine-induced bleeding by protamine sulfate. Thromb Haemost 63(2):271–274PubMedGoogle Scholar
  90. 90.
    Agnelli G, Piovella F, Buoncristiani P, Severi P, Pini M, D’Angelo A et al (1998) Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med 339(2):80–85CrossRefPubMedGoogle Scholar
  91. 91.
    Comerota AJ, Chouhan V, Harada RN, Sun L, Hosking J, Veermansunemi R et al (1997) The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg 226(3):306–313, discussion 13–4CrossRefPubMedPubMedCentralGoogle Scholar
  92. 92.
    Vanek VW (1998) Meta-analysis of effectiveness of intermittent pneumatic compression devices with a comparison of thigh-high to knee-high sleeves. Am Surg 64(11):1050–1058PubMedGoogle Scholar
  93. 93.
    Turpie AG, Hirsh J, Gent M, Julian D, Johnson J (1989) Prevention of deep vein thrombosis in potential neurosurgical patients. A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control. Arch Intern Med 149(3):679–681CrossRefPubMedGoogle Scholar
  94. 94.
    Sachdeva A, Dalton M, Amaragiri SV, Lees T (2010) Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 7, CD001484Google Scholar
  95. 95.
    Geerts WH (2006) Prevention of venous thromboembolism in high-risk patients. Hematol Am Soc Hematol Educ Program 2006:462–466Google Scholar
  96. 96.
    Scales DC, Riva-Cambrin J, Le TL, Pinto R, Cook DJ, Granton JT (2009) Prophylaxis against venous thromboembolism in neurointensive care patients: survey of Canadian practice. J Crit Care 24(2):176–184CrossRefPubMedGoogle Scholar
  97. 97.
    Zareba P, Wu C, Agzarian J, Rodriguez D, Kearon C (2014) Meta-analysis of randomized trials comparing combined compression and anticoagulation with either modality alone for prevention of venous thromboembolism after surgery. Br J Surg 101(9):1053–1062CrossRefPubMedGoogle Scholar
  98. 98.
    Carman TL, Kanner AA, Barnett GH, Deitcher SR (2003) Prevention of thromboembolism after neurosurgery for brain and spinal tumors. South Med J 96(1):17–22CrossRefPubMedGoogle Scholar
  99. 99.
    Cupitt JM (2001) Prophylaxis against thromboembolism in patients with traumatic brain injury: a survey of UK practice. Anaesthesia 56(8):780–785CrossRefPubMedGoogle Scholar
  100. 100.
    Deep K, Jigajinni MV, Fraser MH, McLean AN (2002) Prophylaxis of thromboembolism in spinal injuries–survey of practice in spinal units in the British Isles. Injury 33(4):353–355CrossRefPubMedGoogle Scholar
  101. 101.
    Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW et al (2004) Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(3 Suppl):338S–400SCrossRefPubMedGoogle Scholar
  102. 102.
    Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B et al (2013) International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost 11(1):56–70CrossRefPubMedGoogle Scholar
  103. 103.
    Macdonald RL, Amidei C, Baron J, Weir B, Brown F, Erickson RK et al (2003) Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy. Surg Neurol 59(5):363–372; discussion 72–4CrossRefPubMedGoogle Scholar
  104. 104.
    Nurmohamed MT, van Riel AM, Henkens CM, Koopman MM, Que GT, d’Azemar P et al (1996) Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemost 75(2):233–238PubMedGoogle Scholar
  105. 105.
    Paoletti C, Maubec E, Raggueneau JL, George B, Robine D, Matheron R et al (1989) Clinical tolerance of CY 216 (fraxiparin) in the prevention of thromboembolic accidents after neurosurgery. Agressologie 30(6):363–366PubMedGoogle Scholar
  106. 106.
    Skillman JJ, Collins RE, Coe NP, Goldstein BS, Shapiro RM, Zervas NT et al (1978) Prevention of deep vein thrombosis in neurosurgical patients: a controlled, randomized trial of external pneumatic compression boots. Surgery 83(3):354–358PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of NeurosurgeryBrigham and Women’s Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations

Cite chapter

Buy options